EGFR and non-small cell lung carcinoma: Notably, NSCLC is a cancer for which genotyping of tumor cells, particularly with respect to epidermal growth factor receptor (EGFR) mutations, has demonstrated a remarkable level of success in treatment planning and efficacy (reviewed in [4]).